0001209191-23-042229.txt : 20230713 0001209191-23-042229.hdr.sgml : 20230713 20230713165659 ACCESSION NUMBER: 0001209191-23-042229 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230711 FILED AS OF DATE: 20230713 DATE AS OF CHANGE: 20230713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Struthers Richard Scott CENTRAL INDEX KEY: 0001746298 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38583 FILM NUMBER: 231087269 MAIL ADDRESS: STREET 1: C/O CRINETICS PHARMACEUTICALS, INC. STREET 2: 10222 BARNES CANYON ROAD, BLDG. #2 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Crinetics Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001658247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263744114 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-450-6464 MAIL ADDRESS: STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-07-11 0 0001658247 Crinetics Pharmaceuticals, Inc. CRNX 0001746298 Struthers Richard Scott C/O CRINETICS PHARMACEUTICALS, INC. 10222 BARNES CANYON ROAD, BLDG 2 SAN DIEGO CA 92121 1 1 0 0 President & CEO 1 Common Stock 2023-07-11 4 S 0 24384 20.14 D 656421 I By Family Trust 1 Common Stock 2023-07-12 4 S 0 11459 20.17 D 644962 I By Family Trust 1 Common Stock 2023-07-13 4 S 0 14157 20.35 D 630805 I By Family Trust 1 Common Stock 125522 D Common Stock 1000 I By Spouse Common Stock 90000 I By Family Trust 2 Common Stock 90000 I By Family Trust 3 Common Stock 90000 I By Family Trust 4 The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $20.14 per share. The range of sales prices on the transaction date was $20.10 to $20.25 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $20.17 per share. The range of sales prices on the transaction date was $20.10 to $20.31 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request. The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $20.35 per share. The range of sales prices on the transaction date was $20.10 to $20.68 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request. /s/ Marc Wilson, as attorney-in-fact 2023-07-13